SCHEMBL31428936

SCHEMBL31428936

COc1cc(C=C2C(=O)c3ccccc3N2C(C)=O)ccc1OCC(=O)Nc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.59
▸ KMT2A Q03164 6/20 0.53
▸ POLB P06746 4/20 0.53
▸ CTDSP1 Q9GZU7 2/20 0.53
▸ APOBEC3A P31941 1/20 0.53
▸ APOBEC3G Q9HC16 1/20 0.53
▸ KDM4E B2RXH2 3/20 0.51
▸ HPGD P15428 3/20 0.51
▸ PKM P14618 1/20 0.51
▸ MEN1 O00255 5/20 0.51
▸ CDK2 P24941 1/20 0.50
▸ MAPT P10636 4/20 0.49
▸ NPSR1 Q6W5P4 3/20 0.49
▸ EIF4H Q15056 2/20 0.49
▸ PABPC1 P11940 1/20 0.49
▸ RXFP1 Q9HBX9 1/20 0.49
▸ DUSP3 P51452 1/20 0.49
▸ BLM P54132 1/20 0.49
▸ PTPN5 P54829 1/20 0.49
▸ PTPN11 Q06124 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30163547 0.89 ALDH1A1 (0.53) ALDH1A1KMT2APOLBMEN1MAPT
SCHEMBL30163485 0.86 MAPT (0.53) ALDH1A1KMT2APOLBKDM4EHPGD
SCHEMBL31428792 0.84 ALDH1A1 (0.53) ALDH1A1KMT2AKDM4EHPGDMEN1
SCHEMBL31428917 0.83 MAPT (0.52) ALDH1A1KMT2APOLBKDM4EHPGD
SCHEMBL31429081 0.83 MAPT (0.53) ALDH1A1KMT2APOLBKDM4EHPGD
SCHEMBL31428961 0.83 MAPT (0.51) ALDH1A1KMT2APOLBKDM4EHPGD
SCHEMBL31428963 0.82 MAPT (0.53) ALDH1A1KMT2APOLBKDM4EHPGD
SCHEMBL31428829 0.82 KDM4E (0.58) ALDH1A1KMT2APOLBKDM4EHPGD
SCHEMBL31428790 0.81 ALDH1A1 (0.52) ALDH1A1KMT2APOLBKDM4EHPGD
SCHEMBL30163514 0.80 ALDH1A1 (0.60) ALDH1A1KMT2APOLBKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2025-03-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND BRAF, RAF1, NRAS ALDH1A1 2352/4885KMT2A 2837/4885POLB 3285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback